Navigation Links
Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
Date:1/22/2013

IRVINE, Calif., Jan. 22, 2013 /PRNewswire/ -- PRO-DEX, INC. (Nasdaq: PDEX) and AO Partners Group jointly announced today the results of voting from the Company's Annual Meeting of Shareholders held on January 17, 2013.

(Logo: http://photos.prnewswire.com/prnh/20111025/LA93174LOGO-c)

In June 2012, AO Partners Group, whose members own approximately 22% of the Company's outstanding common stock, nominated a slate of three director nominees to run in opposition to the Company's slate of five director nominees, four of whom were incumbent members of the Company's Board.  At its January 17, 2013 Annual Meeting, shareholders of the Company elected AO's three director nominees, Nicholas J. Swenson , Raymond E. Cabillot and William J. Farrell III , along with two of the Company's nominees, incumbent Chairman William L. Healey and David C. Hovda , to fill the five seats on the Company's new Board of Directors.  Mr. Healey will be the only member of the current Board to continue onto the new Board.          

Michael J. Berthelot , the Company's President and Chief Executive Officer, commented, "We are pleased to have this behind us and we look forward to working with our new board.  Every member of our management team and each of our associates remain committed to designing, developing and manufacturing the best possible products for our customers and in doing so creating value for all of our stakeholders.  We thank our departing board members for their service to our Company and wish them well in the future."

Nick Swenson , member of the AO Partners Group and a newly elected director said, "We thank the shareholders for their support and we look forward to working with our management team as Pro-Dex enters a new chapter in its life."      

About Pro-Dex, Inc.:

Pro-Dex, Inc., with operations in California and Oregon, specializes in the design, development and manufacture of powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets.  Its OMS division designs and manufactures embedded motion control systems serving the medical, dental, semi-conductor and scientific research markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities and high tech manufacturing operations around the world. For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
2. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
3. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
4. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
5. Pro-Dex, Inc. Announces Update Conference Call and Webcast
6. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
7. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
8. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
9. Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
10. KNODE & the University of Louisville Announce Partnership: New site links UofL experts to world
11. Producer Austin Chapman Reaches Millions with Inspiring Story on Hearing Loss; Launches Contest in Partnership with Phonak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):